-

Piper Sandler Expands Biotechnology Equity Research Team with the Addition of Kelsey Goodwin

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Kelsey Goodwin as a director and senior research analyst to the biotechnology equity research team. Goodwin will be based in the Boston office with coverage responsibilities of oncology.

“We are excited to welcome Kelsey to the Piper Sandler platform. She brings a deep understanding and passion for our industry and builds strong relationships to serve clients. We are deeply committed to the biotechnology sector and Kelsey’s addition will only strengthen our industry leading biopharma research practice that is collaborative and energized to provide insights for our clients,” said Michael Cox, co-head of global equities at Piper Sandler.

Prior to joining Piper Sandler, Goodwin spent seven years at Guggenheim, where she focused primarily on the oncology therapeutic area. Before Guggenheim, Kelsey worked in pharmaceutical strategy consulting for three years. Goodwin received a bachelor’s degree in biology from Bowdoin College.

“I am beyond thrilled to join Piper Sandler, a firm with a longstanding reputation not only for its excellence and high-quality research, but also for its people. I look forward to joining the exceptionally talented, hard-working, and collaborative team, and to contributing to the continued success of the firm and its clients,” said Goodwin.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2025. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Nick Lawler

Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions
$Cashtags

Contacts

Nick Lawler

Tel: 212 891-8954
nick.lawler@psc.com

Social Media Profiles
More News From Piper Sandler Companies

Piper Sandler Companies to Announce Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on February 6, 2026

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies to Announce Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on February 6, 2026...

Piper Sandler Expands Healthcare Investment Banking Team with the Addition of Dan Wolf

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Dan Wolf as a managing director in the healthcare investment banking group. Wolf will be based in the Minneapolis office and be focused on advising healthcare technology companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “Dan is a highly respected med tech executive with an impressive track record of advising healthcar...

Piper Sandler Elevates New Co-Heads of Healthcare Investment Banking, Consumer Investment Banking, and Equity Capital Markets

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointments of new co-heads of healthcare investment banking, consumer investment banking and equity capital markets. “These leadership changes reflect the firm’s continued growth, expansion of capabilities, and commitment to delivering exceptional service to our clients. As our business continues to expand, it’s critical that we elevate leaders who can scale our platform,...
Back to Newsroom